Debashis Dutta

984 total citations
26 papers, 694 citations indexed

About

Debashis Dutta is a scholar working on Molecular Biology, Neurology and Physiology. According to data from OpenAlex, Debashis Dutta has authored 26 papers receiving a total of 694 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Neurology and 9 papers in Physiology. Recurrent topics in Debashis Dutta's work include Parkinson's Disease Mechanisms and Treatments (8 papers), Alzheimer's disease research and treatments (6 papers) and Neuroinflammation and Neurodegeneration Mechanisms (6 papers). Debashis Dutta is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (8 papers), Alzheimer's disease research and treatments (6 papers) and Neuroinflammation and Neurodegeneration Mechanisms (6 papers). Debashis Dutta collaborates with scholars based in United States, India and Russia. Debashis Dutta's co-authors include Kalipada Pahan, Kochupurackal P. Mohanakumar, Malabendu Jana, R. P. Singh, Amit K. Naskar, Avik Roy, Ramesh Kumar Paidi, Susanta Mondal, Sumita Raha and Usha Rajamma and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Journal of Neuroscience.

In The Last Decade

Debashis Dutta

26 papers receiving 687 citations

Peers

Countries citing papers authored by Debashis Dutta

Since Specialization

Citations

This map shows the geographic impact of Debashis Dutta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debashis Dutta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debashis Dutta more than expected).

Fields of papers citing papers by Debashis Dutta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debashis Dutta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debashis Dutta. The network helps show where Debashis Dutta may publish in the future.

Co-authorship network of co-authors of Debashis Dutta

This figure shows the co-authorship network connecting the top 25 collaborators of Debashis Dutta. A scholar is included among the top collaborators of Debashis Dutta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debashis Dutta. Debashis Dutta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cinnamic acid, a natural plant compound, exhibits neuroprotection in a mouse model of Sandhoff disease via PPARα 2024 ·PubMed ·Sumita Raha, Ramesh Kumar Paidi, Debashis Dutta, Kalipada Pahan	2
2	Nebulization of low-dose aspirin ameliorates Huntington’s pathology in N171-82Q transgenic mice 2024 ·PubMed ·Susanta Mondal, (unknown), Suresh B. Rangasamy, Debashis Dutta, Kalipada Pahan	2
3	Oligodendrocyte Dysfunction in Tauopathy: A Less Explored Area in Tau-Mediated Neurodegeneration 2024 ·Cells ·(unknown), Debashis Dutta	4
4	Activation of PPARα Exhibits Therapeutic Efficacy in a Mouse Model of Juvenile Neuronal Ceroid Lipofuscinosis 2023 ·Journal of Neuroscience ·Malabendu Jana, Debashis Dutta, (unknown), Kalipada Pahan	10
5	Tau fibrils induce glial inflammation and neuropathology via TLR2 in Alzheimer’s disease–related mouse models 2023 ·Journal of Clinical Investigation ·Debashis Dutta, Malabendu Jana, Ramesh Kumar Paidi, (unknown), Sumita Raha, (unknown), Kalipada Pahan	47
6	Lipid-Lowering Drug Gemfibrozil Protects Mice from Tay-Sachs Disease via Peroxisome Proliferator-Activated Receptor α 2023 ·Cells ·Sumita Raha, Debashis Dutta, Ramesh Kumar Paidi, Kalipada Pahan	1
7	Treadmill exercise reduces α-synuclein spreading via PPARα 2022 ·Cell Reports ·Debashis Dutta, Ramesh Kumar Paidi, Sumita Raha, Avik Roy, Sujyoti Chandra, Kalipada Pahan	27
8	Protection of dopaminergic neurons in hemiparkinsonian monkeys by flavouring ingredient glyceryl tribenzoate 2022 ·PubMed ·Suresh B. Rangasamy, Debashis Dutta, Susanta Mondal, (unknown), (unknown), Goutam Chandra, Kalipada Pahan	3
9	Harnessing the Therapeutic Potential of the Nrf2/Bach1 Signaling Pathway in Parkinson’s Disease 2022 ·Antioxidants ·Manuj Ahuja, Navneet Ammal Kaidery, Debashis Dutta, Otis C. Attucks, (unknown), Irina G. Gazaryan, Mitsuyo Matsumoto, Kazuhiko Igarashi, Sudarshana M. Sharma, Bobby Thomas	26
10	Alleviation of Huntington pathology in mice by oral administration of food additive glyceryl tribenzoate 2021 ·Neurobiology of Disease ·Debashis Dutta, (unknown), Ramesh Kumar Paidi, Kalipada Pahan	14
11	Selective targeting of the TLR2/MyD88/NF-κB pathway reduces α-synuclein spreading in vitro and in vivo 2021 ·Nature Communications ·Debashis Dutta, Malabendu Jana, (unknown), Susanta Mondal, Avik Roy, Kalipada Pahan	131
12	Selective Inhibition of the Interaction between SARS-CoV-2 Spike S1 and ACE2 by SPIDAR Peptide Induces Anti-Inflammatory Therapeutic Responses 2021 ·The Journal of Immunology ·Ramesh Kumar Paidi, Malabendu Jana, Rama K. Mishra, Debashis Dutta, Kalipada Pahan	21
13	Activation of PPARα enhances astroglial uptake and degradation of β-amyloid 2021 ·Science Signaling ·Sumita Raha, Arunava Ghosh, Debashis Dutta, Dhruv Patel, Kalipada Pahan	42
14	HYALURONIC ACID-DOCETAXEL CONJUGATE LOADED NANOLIPOSOMES FOR TARGETING TUMOR CELLS 2020 ·International Journal of Applied Pharmaceutics ·(unknown), Lila Kanta Nath, Debashis Dutta	4
15	Targeting Gemcitabine hydrochloride to tumor microenvironment through stimuli-responsive Nano-conjugate: Synthesis, characterization, and in vitro assessment 2020 ·Journal of Drug Delivery Science and Technology ·(unknown), (unknown), Lila Kanta Nath, Prithviraj Chakraborty, Debashis Dutta	8
16	Reduction of Lewy Body Pathology by Oral Cinnamon 2020 ·Journal of Neuroimmune Pharmacology ·Sumita Raha, Debashis Dutta, Avik Roy, Kalipada Pahan	10
17	Low Levels of Prohibitin in Substantia Nigra Makes Dopaminergic Neurons Vulnerable in Parkinson’s Disease 2017 ·Molecular Neurobiology ·Debashis Dutta, (unknown), (unknown), R. P. Singh, Amit K. Naskar, Ramesh Kumar Paidi, Kochupurackal P. Mohanakumar	44
18	Tea and Parkinson's disease: Constituents of tea synergize with antiparkinsonian drugs to provide better therapeutic benefits 2015 ·Neurochemistry International ·Debashis Dutta, Kochupurackal P. Mohanakumar	27
19	Melatonin enhances L ‐ DOPA therapeutic effects, helps to reduce its dose, and protects dopaminergic neurons in 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced parkinsonism in mice 2015 ·Journal of Pineal Research ·Amit K. Naskar, (unknown), R. P. Singh, Debashis Dutta, Kochupurackal P. Mohanakumar	59
20	Quercetin Improves Behavioral Deficiencies, Restores Astrocytes and Microglia, and Reduces Serotonin Metabolism in 3‐Nitropropionic Acid‐Induced Rat Model of Huntington's Disease 2013 ·CNS Neuroscience & Therapeutics ·Joy Chakraborty, R. P. Singh, Debashis Dutta, Amit K. Naskar, Usha Rajamma, Kochupurackal P. Mohanakumar	110

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact